Skip to main content

Table 4 Absolute cost and effects calculated for an estimated 70'000 travellers from Switzerland to West Africa for the three different estimates on current recourse to malaria chemoprophylaxis

From: Cost-effectiveness analysis of malaria chemoprophylaxis for travellers to West-Africa

Cost-effectiviness analysis with the three different estimated 'recourse to malaria chemoprophylaxis'

55%

68.70%

82.40%

 

Current situation of no reimbursement

80% reimbursement strategy

Current situation of no reimbursement

80% reimbursement strategy

Current situation of no reimbursement

80% reimbursement strategy

Estimated number of travellers from Switzerland to West Africa

70'000

Cost per year (€) likliest

4'581'654

3'565'716

3'503'346

3'175'326

2'425'038

2'784'936

Effect per year likliest

      

   Malaria cases

837

438

624

346

410

254

   Malaria-related deaths

10

5

7

4

5

3

Effectiveness of 80% reimbursement strategy

      

   Malaria cases prevented

-

399

-

278

-

156

   Malaria-related deaths prevented

-

5

-

3

-

2